Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cipla
Medtronic
Queensland Health
US Army
Citi

Generated: August 25, 2019

DrugPatentWatch Database Preview

Patent: 10,094,836

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,094,836
Title:SLCO1B3 genotype
Abstract: The invention relates methods of identifying and predicting inter-patient differences in prognostic prediction for survival in androgen independent prostate cancer. It further related to methods for determining and exploiting such differences to improve medical outcomes. Moreover, it provides methods for determining if a subject has prostate cancer.
Inventor(s): Figg; William D. (Fairfax, VA), Sparreboom; Alex (Memphis, TN), Hamada; Akinobu (Tokyo, JP), Price; Douglas K. (Fairfax, VA), Sissung; Tristan M. (Annandale, VA)
Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC)
Application Number:12/522,480
Patent Claims:see list of patent claims

Details for Patent 10,094,836

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2027-01-08 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2027-01-08 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Try a Free Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2027-01-08 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Harvard Business School
McKinsey
Baxter
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.